CC Community News Digest (week of August 3-9)
Assorted news links from the last week:
Study Offers Insights on Health Problems among AYA Cancer Survivors
Medical trial aims to identify those at risk of heart damage following cancer treatment Australian researchers taking a very broad look at the effect of cancer treatment on heart health.
US FDA Grants Rare Pediatric Disease Designation (RPDD) to Paxalisib for DIPG, a big win for the Creating Hope Act (which needs to be permanently reauthorized by the end of September)
Risk-Stratified Therapy Reduces Late Morbidity, Mortality in Pediatric Acute Lymphoblastic Leukemia
Children With Cancer Not Experiencing as Severe COVID-19 as Initially Feared
Preserving Childhood Cancer Care Amid a Pandemic, U.S. News & World Report
Categories
- Blog Posts (97)
- Explainer Post (12)
- Guest Blogs (16)
- Member Blogs (40)
- Survivorship Matters Blog (9)
- CAC2 News (25)
- Collaborative Achievements (14)
- Community News (256)
- In Memoriam (2)
- News Digest (206)
- Webinars (64)
Tags
Advocacy (55)
Annual Summit (7)
Appropriations (1)
Awareness (26)
AYA (2)
Bereavement (1)
Best Practices (14)
Biorepositories (2)
CAC2 News (9)
CAC2 Projects (11)
Call to Action (26)
Call to Action Prevention (1)
Care Giving (1)
Clinical Trials (11)
COG (2)
Collaboration (14)
Data (15)
Delayed Diagnosis (2)
Digest (12)
Drug Development (12)
Drug Development collaboration (1)
Drug Shortages (3)
Ethics (1)
Family Support (16)
FDA (2)
Funding Research (7)
Genomics (6)
Global News (4)
Industry Perspective (5)
Member Access (12)
NCI (3)
Nutrition (2)
Post-Mortem Tissue Donation (1)
Prevention (3)
Psychosocial Support (6)
Rare and Ultra Rare Cancer (1)
Rare Cancers (1)
Regulations (3)
Research (36)
Research Data (2)
Research Tissue Donation (1)
Social Work (1)
state advocacy (1)
Survivorship (29)
Venture Philanthropy (3)